VKTX
Viking Therapeutics Inc
NASDAQ: VKTX · HEALTHCARE · BIOTECHNOLOGY
$30.00
-3.78% today
Updated 2026-05-01
Market cap
$3.63B
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-3.19
Dividend yield
—
52W range
$23 – $43
Volume
2.4M
WallStSmart proprietary scores
23
out of 100
Grade: F
Strong Sell
Investment rating
4.3
Growth
C5.0
Quality
C+3.0
Profitability
D5.0
Valuation
C+—/9
Piotroski F-Score
—
—
Altman Z-Score
—
—
Industry rank
—
View all highly rated stocks (75+) →204 stocks currently score above 75
Price targets
Analyst target
$92.50
+208.33%
12-Month target
—
—
Intrinsic (DCF)
—
Margin of safety
—
5 Strong Buy12 Buy2 Hold0 Sell0 Strong Sell
Price chart
X-Ray snapshot
Strengths
Insufficient data
Risks
- Thin margins at 0.00%
- Negative free cash flow $-85.29M
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 | $0.00 | — |
| Net income | $-68.87M | $-85.89M | $-109.96M | $-359.64M | $-158.32M |
| EPS | — | — | — | — | $-3.19 |
| Free cash flow | $-48.40M | $-73.38M | $-87.79M | $-278.69M | $-85.29M |
| Profit margin | — | — | — | — | — |
Peer comparison
Smart narrative
Viking Therapeutics Inc trades at $30.00. Our Smart Value Score of 23/100 indicates the stock is weak.
Frequently asked questions
What is Viking Therapeutics Inc's stock price?
Viking Therapeutics Inc (VKTX) trades at $30.00.
Is Viking Therapeutics Inc overvalued?
Smart Value Score 23/100 (Grade F, Strong Sell).
What is the price target of Viking Therapeutics Inc (VKTX)?
The analyst target price is $92.50, representing +208.3% upside from the current price of $30.00.
Company info
SectorHEALTHCARE
IndustryBIOTECHNOLOGY
CountryUSA
ExchangeNASDAQ
CurrencyUSD
Quick metrics
P/S ratio—
ROE-47.30%
Beta0.82
50D MA$33.53
200D MA$32.77
Shares out0.12B
Float0.11B
Short ratio—
Avg volume2.4M
Performance
1 week—
1 month—
3 months—
YTD—
1 year—
3 years—
5 years—